Nachrichten zur Pixium Vision S.A. Aktie

Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedings

Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the…

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD…

Pixium Vision announces the conversion of the safeguard proceedings into receivership

Pixium Vision announces the conversion of the safeguard proceedings into receivership…

Pixium Vision announces its financial results for H1 2023 and provides update

Pixium Vision announces its financial results for H1 2023 and provides update …

Pixium Vision announces the launch of a process to find buyers

Pixium Vision announces the launch of a process to find buyers…

Pixium Vision announces the opening of safeguard proceedings

Pixium Vision announces the opening of safeguard proceedings…

Pixium Vision announces the completion of the reverse stock split of its shares on the basis of 1 new share for 50 existing shares and the start of trading of the shares resulting after the completion of the reverse split as of Sep 21, 2023

…

Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing shares

Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the…

Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing facility

Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing…

Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit

Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit...…

Pixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023

Pixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023...…

Pixium Vision announces the availability of its annual report for the financial year 2022

Pixium Vision announces the availability of itsannual report for the financial year 2022...…

Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023

Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31,…

Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD

Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD...…

XFRA : CAPITAL ADJUSTMENT INFORMATION - 21.03.2023 - FR0011950641

Das Instrument PXH FR0011950641 PIXIUM VISION SA EO -,02 EQUITY wird ex Kapitalmassnahme gehandelt am 21.03.2023 The instrument PXH FR0011950641…

Pixium Vision announces termination of convertible note financing agreement with US-based healthcare investor ESGO

Pixium Vision announces termination of convertible note financing agreement with US-based healthcare investor ESGO...…

Pixium Vision announces its cash position at 31 December 2022 and provides an update on its activities

Pixium Vision announces its cash position at...…

Pixium Vision convenes an Extraordinary General Meeting of Shareholders on February 15, 2023

Pixium Vision convenes an Extraordinary General Meeting of Shareholders on February 15, 2023...…

Pixium Vision announces peer-reviewed publications demonstrating the potential of the Next Generation PRIMA implant to restore vision at five times higher resolution than current implant

Pixium Vision announces peer-reviewed publications demonstrating the potential of the Next Generation PRIMA implant to restore vision at five times…

Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products

Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products...…

Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024

Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023…

Pixium Vision announces participation in investor conferences in November and December 2022

Pixium Vision announces participation in investor conferences in November and December 2022...…

Pixium Vision announces its cash position at 30 September 2022 and provides an update on its activities

Pixium Vision announces its cash position at...…

Pixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural Engineering

Pixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of…

Pixium Vision announces participation in investor conferences and events in October 2022

Pixium Vision announces participation in investor conferences and events in October 2022...…

dpa-AFX ProFeed